Trials / Unknown
UnknownNCT05478356
The Effects of Low-dose Atropine and Orthokeratology in Pediatric Myopia Control
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Evidence Based Cataract Study Group · Academic / Other
- Sex
- All
- Age
- 8 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
Both orthokeratology and atropine eye drops are effective methods for myopia control, but few studies have compared them all together simultaneously. Therefore, the primary aim of the present study was to compare the effect of orthokeratology versus low-dose (0.01% and 0.02%) atropine on the control of myopia progression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | low-dose atropine eye drops | low-dose atropine eye drops |
| DEVICE | orthokeratology | orthokeratology, ortho-K lenses |
Timeline
- Start date
- 2022-08-01
- Primary completion
- 2023-08-31
- Completion
- 2023-08-31
- First posted
- 2022-07-28
- Last updated
- 2022-07-28
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05478356. Inclusion in this directory is not an endorsement.